We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Wearable Sensor Could Reduce Catheter-Related Bloodstream Infections

By HospiMedica International staff writers
Posted on 27 Dec 2023

Hospitalized patients already face numerous challenges, and the risk of acquiring a catheter-related bloodstream infection only adds to their burden. More...

These infections, often life-threatening, can prolong hospital stays and escalate treatment costs. They commonly occur when a central venous catheter, or a central line, is placed in a large vein leading directly to the heart. These catheters are crucial for critically ill patients, enabling rapid medication administration or heart function monitoring.

In response to this critical issue, researchers at Texas A&M University (College Station, TX, USA) are pioneering a catheter dressing designed to reduce the frequency and severity of catheter-related bloodstream infections. This innovative dressing, integrated with the catheter, will incorporate wireless sensors capable of detecting extremely low levels of bacterial growth on the skin. Currently, no catheters in the market can automatically and swiftly detect bacterial growth at the catheter-insertion site. Previous attempts by other researchers to detect bacteria indirectly, such as through variations in skin pH, haven't addressed the need for direct bacteria detection.

Often, initial signs of infection might be overlooked because the dressing conceals symptoms like swelling or drainage. Any delay in detecting an infection provides time for it to escalate. Once an infection is suspected, healthcare providers must await blood test results to confirm its presence and might resort to broad-spectrum antibiotics while waiting, which can lead to antibiotic resistance.

The successful development of this dressing with embedded wearable sensors signifies a potential paradigm shift. It can alert healthcare providers to bacterial growth without the need to remove the dressing, leading to prompt and more accurate detection. This advancement could pave the way for immediate and targeted antibiotic treatments, reducing the prevalence of antibiotic resistance. Nonetheless, the research team faces several hurdles, including the challenge of detecting exceedingly low bacterial levels, ensuring the dressing's flexibility, incorporating a durable adhesive, and selecting materials that minimize allergic reactions in patients.

Related Links:
Texas A&M University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.